Discover and read the best of Twitter Threads about #ow2021

Most recents (4)

1/ It is no surprise that Semaglutide is the bell of the pharmacotherapy ball. Let's review some key takeaways from the STEP trials to understand why SEMA 2.4 mg is so exciting.
*credit to Dr. Wadden. #OW2021

STEP 3
2/ Intervention: Intensive Behavioral Therapy + Low Calorie Diet +/- SEMA 2.4 mg #OW2021
3/
Control arm: IBT + LCD lost ~6% BW.
vs.
Experimental arm: IBT/LCD/SEMA 2.4 lost 16% BW. #OW2021
Read 6 tweets
1/ Circadian Fasting: by Dr. Chow
The theme of the day => TRE researchers have a lot to say about @ethanjweiss's research. #OW2021 ImageImage
2/ Eating in the AM is possibly more satiating. #OW2021 Image
3/ Early TRE, in the absence of weight loss, elicits a more optimal metabolic response: #OW2021
⬇️ insulin
⬆️ insulin sensitivity
⬇️ hunger
⬇️ BP
‼️ But is it practical? Image
Read 4 tweets
1/ Dr. Lee Kaplan: What Does the Future of Obesity Care Look Like? #OW2021

Every time I hear Dr. Kaplan speak, I am blown away by his knowledge and perspective. He, once again, delivered a masterclass on obesity.

Point #1: We are undertreating obesity Image
Point #2: An active, involuntary physiological system determines body fatness at any one time. #OW2021 Image
Point #3: All our available interventions help to readjust down the increased fat mass setpoint (in theory). #OW2021 ImageImageImage
Read 8 tweets
1/ Future of Obesity Treatments? #OW2021

Meet the candidates:
1) AM833 +/- Semaglutide 2.4 mg; combo therapy resulted in 15-17% at 20 weeks with no evidence of nadir, suggesting even greater wt loss (likely >20%).
by Dr. Rubino ImageImageImage
2/ Tirzepatide; hard to imagine a future without tirzepatide (as long as safety & tolerability remain) for the treatment of metabolic dz when >10% wt loss and -2.5% A1c are avg results. Also, >50% of participants achieved normoglycemia with most doses‼️
↪️by Dr. Frias #OW2021 ImageImageImageImage
3/ Setmelanotide; MC4R agonist targets central POMC/MC4R pathway in hypothalamus. Currently reserved for congenital obesity.
➡️ 1 in 300 carry MC4R loss of fxn variant (predisposes to wt gain)
➡️ 6 in 300 carry MC4R GoF variant that protects against wt gain
↪️ by @Farooqi_Lab ImageImageImage
Read 6 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!